Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 1351 to 1400 of 2003

TitleReference numberPublishedLast updated
Percutaneous coblation of the intervertebral disc for low back pain and sciaticaIPG543
Percutaneous electrothermal treatment of the intervertebral disc annulus for low back pain and sciaticaIPG544
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicatedTA377
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapyTA378
Nintedanib for treating idiopathic pulmonary fibrosisTA379
Panobinostat for treating multiple myeloma after at least 2 previous treatmentsTA380
Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal)TA382
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failedTA375
Guidance on the use of imatinib for chronic myeloid leukaemiaTA70
Older people: independence and mental wellbeingNG32
Insertion of a subretinal prosthesis system for retinitis pigmentosaIPG537
Joint distraction for ankle osteoarthritisIPG538
Radiofrequency ablation for symptomatic interdigital (Morton's) neuromaIPG539
Electrical stimulation of the lower oesophageal sphincter for treating gastro-oesophageal reflux diseaseIPG540
Repetitive transcranial magnetic stimulation for depressionIPG542
Care of dying adults in the last days of lifeNG31
Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tearsTA369
Bortezomib for previously untreated mantle cell lymphomaTA370
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritisTA373
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapyTA374
Oral health promotion: general dental practiceNG30
Transition between inpatient hospital settings and community or care home settings for adults with social care needsNG27
Implantation of a corneal graft–keratoprosthesis for severe corneal opacity in wet blinking eyesIPG534
Living-donor liver transplantationIPG535
Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retentionIPG536
Children's attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into careNG26
Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis CTA365
Vortioxetine for treating major depressive episodesTA367
Ledipasvir–sofosbuvir for treating chronic hepatitis CTA363
Blood transfusionNG24
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesionsDG19
Older people with social care needs and multiple long-term conditionsNG22
Implanting a baroreceptor stimulation device for resistant hypertensionIPG533
Developing and updating local formulariesMPG1
Tolvaptan for treating autosomal dominant polycystic kidney diseaseTA358
Idelalisib for treating chronic lymphocytic leukaemiaTA359
Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal)TA362
Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onsetNG16
Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay)DG18
Home care: delivering personal care and practical support to older people living in their own homesNG21
Coeliac disease: recognition, assessment and managementNG20
Transcranial direct current stimulation (tDCS) for depressionIPG530
Preoperative high dose rate brachytherapy for rectal cancerIPG531
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapyTA352
Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)TA353
Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolismTA354
Antimicrobial stewardship: systems and processes for effective antimicrobial medicine useNG15
Joint distraction for knee osteoarthritis without alignment correctionIPG529
Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean sectionIPG528
Naloxegol for treating opioid‑induced constipationTA345

Results per page

  1. 10
  2. 25
  3. 50
  4. All